EXAS vs OTIS · rev $2.76B vs P/E 19, rev $7.42B
EXACT Sciences Corporation (EXAS) versus Otis Worldwide Corp (OTIS) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Otis Worldwide Corp (OTIS) is a specialty industrial machinery company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported OTIS revenue for 2026-06-30 was $7.42B. Net income was $768.0M. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
EXAS currently screens at market cap $20.03B. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
Not investment advice. Open the EXAS and OTIS stock pages for the full models.
Not investment advice.